Compounds > 3-(2-4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone

3-(2-4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone and Cardiomyopathies

3-(2-4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone has been researched along with Cardiomyopathies* in 1 studies

Other Studies

1 other study(ies) available for 3-(2-4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone and Cardiomyopathies

ArticleYear
Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation.
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:2

    Topics: Animals; Cardiomyopathies; Mice; Mice, Obese; Mitophagy; Myocytes, Cardiac; Obesity; Protein Kinases; Ubiquitin-Protein Ligases

2023